New Research Institute to Transform Protein Science: Q&A with Timothy Springer, Ph.D. [Drug Discovery and Development Magazine]

June 22, 2017
monoclonal antibody


The Institute for Protein Innovation (IPI) opened its doors last month on the campus of Harvard Medical School.

Founded by Timothy Springer, Ph.D., Latham Family Professor at Harvard Medical School and Boston Children’s Hospital along with Andrew C. Kruse, Ph.D., Assistant Professor, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, the IPI hopes to bridge the gap between genomes and therapeutics.